Get the Weekly Intelligence Brief — top committee picks every Sunday.

ALGN vs TXG

Align Technology vs 10x Genomics, Inc. — AI-powered side-by-side comparison
ALGN
Align Technology
73
Buy
VS
TXG
10x Genomics, Inc.
53
Watch
MetricALGNTXG
AI Score 73 53
Price $172.86 $58.48
P/E Ratio 30.03× -99.12×
ROE 10.1% -5.5%
Revenue Growth YoY
Gross Margin 66.5% 70.0%
Debt / Equity 0.03× 0.10×
Dividend Yield 0.0% 0.0%
RSI (14) 55.1 79.3
Beta 1.653 2.039
Expected Upside +7.7%

AI Committee View

Current Innellis committee reasoning for ALGN versus TXG.
ALGN leads by 20 points.

ALGN scores 73/100 (Buy) versus TXG at 53/100 (Watch).

ALGN Committee View
100% agreement
5 analysts

The primary driver is quarter-over-quarter growth rate is accelerating, not just positive. The main limiting factor is 2 existing position pair(s) are highly correlated already. The committee is constructive but not yet at full conviction.

Bull Case
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
  • MACD histogram positive -- bullish momentum — Technical
  • Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
  • Both daily and weekly trends are bearish — strong multi-timeframe downtrend.
TXG Committee View
50% agreement
6 analysts

The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Growth Analyst remains cautious — revenue declining -4.3% yoy -- this is not a growth story right now. This disagreement is itself the signal — the setup is not clean in either direction.

Bull Case
  • Price structure making higher highs and higher lows — Technical
  • MACD histogram positive -- bullish momentum — Technical
  • Trend and market structure agree -- coherent bullish picture — Technical
Bear Case
  • ROE of only -9.3% -- cheap may mean cheap for a reason — Value
  • Revenue declining -4.3% YoY -- this is not a growth story right now — Growth
  • RSI at 79 is in overbought territory — Technical
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
ALGN Full Analysis TXG Full Analysis